Pharmacodynamic modelling of rocuronium in adolescents with Duchenne muscular dystrophy

European Journal of Anaesthesiology

Volumn 26, Issue 2, 2009, Pages 105-110

  Ihmsen, Harald ^a   Viethen, Vanessa ^a   Forst, Juergen ^a   Schwilden, Helmut ^a   Schmitt, Hubert J ^a   Muenster, Tino ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Duchenne muscular dystrophy; Neuromuscular block; Neuromuscular disease; Pharmacodynamics; Pharmacokinetics; Pharmacology; Rocuronium

Indexed keywords

MIDAZOLAM; PROPOFOL; ROCURONIUM; SUFENTANIL; ANDROSTANE DERIVATIVE;

ADOLESCENT; ANESTHETIC RECOVERY; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTINUOUS INFUSION; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE TITRATION; DRUG HALF LIFE; DUCHENNE MUSCULAR DYSTROPHY; GENERAL ANESTHESIA; HUMAN; MALE; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; PHARMACODYNAMICS; PREMEDICATION; TIME TO MAXIMUM PLASMA CONCENTRATION; BIOLOGICAL MODEL; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEALTH;

ADOLESCENT; ANDROSTANOLS; CHILD; HEALTH; HUMANS; MALE; MODELS, BIOLOGICAL; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 61549085890     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32831aed11     Document Type: Article

References (19)

1. Blake DJ, Kroger S. The neurobiology of Duchenne muscular dystrophy: learning lessons from muscle? Trends Neurosci 2000; 23 :92-99.
2. Emery AE. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord 1991;1:19-29.
3. Ririe DG, Shapiro F, Sethna NF. The response of patients with Duchenne's muscular dystrophy to neuromuscular blockade with vecuronium. Anesthesiology 1998;88:351-354.
4. Schmidt J, Muenster T, Wick S, et al. Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy. Br J Anaesth 2005;95:769-772. (Pubitemid 41762375)
5. Wick S, Muenster T, Schmidt J, et al. Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy. Anesthesiology 2005;102:915-919. (Pubitemid 40586531)
6. -1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy. Paediatr Anaesth 2006;16:840-845.
7. Viby-Mogensen J, Engbaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996;40:59-74.
8. Tuk B, Danhof M, Mandema JW. The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates. J Pharmacokinet Biopharm 1997;25:39-62.
9. Wierda JM, Meretoja OA, Taivainen T, Proost JH. Pharmacokinetics and pharmacokinetic: dynamic modelling of rocuronium in infants and children. Br J Anaesth 1997;78:690-695.
10. Wierda JM, Kleef UW, Lambalk LM, et al. The pharmacodynamics and pharmacokinetics of Org 9426, a new nondepolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth 1991;38:430-435.
11. Bock M, Klippel K, Nitsche B, et al. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia. Br J Anaesth 2000;84:43-47.
12. Dragne A, Varin F, Plaud B, Donati F. Rocuronium pharmacokinetic- pharmacodynamic relationship under stable propofol or isoflurane anesthesia. Can J Anaesth 2002;49:353-360.
13. Kopman AF, Chin WA, Moe J. Dose-response relationship of rocuronium: a comparison of electromyographic vs. acceleromyographic-derived values. Acta Anaesthesiol Scand 2005;49:323-327.
14. Kumar N, Mirakhur RK, Symington MJ, McCarthy GJ. Potency and time course of action of rocuronium during desflurane and isoflurane anaesthesia. Br J Anaesth 1996;77:488-491.
15. Saldien V, Vermeyen KM, Wuyts FL. Target-controlled infusion of rocuronium in infants, children, and adults: a comparison of the pharmacokinetic and pharmacodynamic relationship. Anesth Analg 2003;97:44-49.
16. Taivainen T, Meretoja OA, Erkola O, et al. Rocuronium in infants, children and adults during balanced anaesthesia. Paediatr Anaesth 1996;6:271-275. (Pubitemid 126439749)
17. Woloszczuk-Gebicka B, Wyska E, Grabowski T, et al. Pharmacokinetic- pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children. Paediatr Anaesth 2006;16:761-768.
18. Woolf RL, Crawford MW, Choo SM. Dose-response of rocuronium bromide in children anesthetized with propofol: a comparison with succinylcholine. Anesthesiology 1997;87:1368-1372.
19. Wulf H, Ledowski T, Linstedt U, et al. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia. Can J Anaesth 1998;45:526-532.